Evaluation of the potential genotoxicity of the phosphate binder lanthanum carbonate

Mutagenesis

Volumn 20, Issue 1, 2005, Pages 29-37

  Damment, S J P ^a   Beevers, C ^b   Gatehouse, D G ^b  

^a Shire Pharmaceuticals   (United Kingdom)

^b Department of Genetic and Molecular Toxicology   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

CLASTOGEN; DNA; LANTHANUM CARBONATE; LANTHANUM CHLORIDE; PHOSPHATE BINDING AGENT;

ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; BACTERIAL STRAIN; CHO CELL; CHROMOSOME ABERRATION; CONTROLLED STUDY; DNA SYNTHESIS; DRUG BLOOD LEVEL; DRUG CYTOTOXICITY; DRUG SCREENING; ESCHERICHIA COLI; FEMALE; GENE MUTATION; GENOTOXICITY; LIVER MITOCHONDRION; MALE; MICRONUCLEUS TEST; MOUSE; MUTAGENICITY; NONHUMAN; PRIORITY JOURNAL; RAT; RAT STRAIN; SALMONELLA TYPHIMURIUM;

ANIMALS; CHO CELLS; CRICETINAE; CRICETULUS; HYPOXANTHINE PHOSPHORIBOSYLTRANSFERASE; LANTHANUM; MALE; MICE; MICRONUCLEUS TESTS; MUTAGENS; PHOSPHATES; PHOSPHORIC ACID ESTERS; RATS;

BACTERIA (MICROORGANISMS); CRICETINAE; CRICETULUS GRISEUS; ESCHERICHIA COLI; RODENTIA; SALMONELLA TYPHIMURIUM; TYPHIMURIUM;

EID: 14744291660     PISSN: 02678357     EISSN: None     Source Type: Journal    
DOI: 10.1093/mutage/gei003     Document Type: Article

References (30)

1. Ames,B.N., McCann,J. and Yamasaki,E. (1975) Methods of detecting carcinogens and mutagens with the Salmonella/mammalian microsomal mutagenicity test. Mutat. Res., 31, 347-354.
2. Armitage,P. (1971) Statistical Methods in Medical Research, 1st Edn. Stockwell Scientific, London, UK.
3. Behets,G.J., Verberckmoes,S.C., D'Haese,P.C. and DeBroe,M.E. (2004) Lanthanum carbonate: a new phosphate binder. Curr. Opin. Nephrol. Hypertens., 13, 403-409.
4. Damment,S.J.P. and Gill,M. (2003) The pharmacokinetics and tissue distribution of lanthanum carbonate (Fosrenol), a new non-aluminium, non-calcium phosphate binder. J. Am. Soc. Nephrol., 14, 204A, ABSTRACT F-P0653.
5. Damment,S.J.P., Greaves,P., and Downes,N. (2003) The toxicology of lanthanum carbonate (Fosrenol), a new non-aluminium, non-calcium phosphate binder. J. Am. Soc. Nephrol., 14, 204A, ABSTRACT F-P0651.
6. Das,T., Sharma,A. and Talukder,G. (1988) Effects of lanthanum in cellular systems. A review. Biol. Trace Elem. Res., 18, 201-228.
7. D'Haese,P.C., Spasovski,G.B., Sikole,A. et al. (2003) A multicentre study on the effects of lanthanum carbonate (Fosrenol) and calcium carbonate on renal bone disease in dialysis patients. Kidney Int., 85 (suppl.), S73-S78.
8. Dunnett,C.W. and Goldsmith,C. (1981) When and how to do multiple comparisons. In Buncher,C.R. and Tsay,J.Y. (eds), Statistics in the Pharmaceutical Industry. Marcel Dekker, New York, NY, Ch. 16, pp. 397-433.
9. Environmental Mutagen Information Centre (1981) EMIC database. Mutat. Res., 87, 211-297.
10. Evans,C.H. (1990) Biochemistry of the Lanthanides. Plenum Press, New York, NY.
11. Gatehouse,D., Haworth,S., Cebula,T. et al. (1994) Recommendations for the performance of bacterial mutation assays. Mutat. Res., 312, 217-233.
12. Hayashi,M., Tice,R., MacGregor,J.T. et al. (1994) In vivo rodent erythrocyte micronucleus assay. Mutat. Res., 312, 293-304.
13. International Conference on Harmonization (1995a) Topic S2A. Genotoxicity: guidance on specific aspects of regulatory genotoxicity tests for pharmaceuticals. Harmonized tripartite guideline CPMP/ICH/141/95, approved September 1995. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use.
14. International Conference on Harmonization (1995b) Topic S2B. Genotoxicity: a standard battery for genotoxicity testing of pharmaceuticals. Harmonised tripartite guideline. CPMP/ICH/174/95, approved September 1997. International Conference on Harmonization of Technical Requirements for Registration of Pharmaceuticals for Human Use.
15. Kanematsu,N., Hara,M. and Kada,T. (1980) Rec assay and mutagenicity on metal compounds. Mutat. Res., 77, 109-116.
16. Kennelly,J.C., Lefevre,P.A., Dean,S.W. et al. (1993) In vivo rat liver UDS assay. In Report of the UKEMS Sub-committee on Guidelines for Mutagenicity Testing, Part II Revised. Cambridge University Press, Cambridge, UK, pp. 52-77.
17. Kirkland,D.J. (Ed.) (1989) Statistical Evaluation of Mutagenicity Test Data. UKEMS Sub-committee Guidelines for Mutagenicity Testing. Report. Part III. University Press, Cambridge, UK.
18. Kirkland,D.J. and Müller,L. (2000) Interpretation of the biological relevance of genotoxicity test results: the importance of thresholds. Mutat. Res., 464, 137-147.
19. Maron,D. and Ames,B.N. (1983) Revised methods for the Salmonella mutagenicity test. Mutat. Res., 113, 173-215.
20. Müller,L. and Kasper,P. (2000) Human biological relevance and the use of threshold-arguments in regulatory genotoxicity assessment: experience with pharmaceuticals. Mutat. Res., 464, 19-34.
21. OECD (1993) OECD Guidelines for the Testing of Chemicals: Genotoxicity, revised and new guidelines, adopted 1993. Organization for Economic Cooperation and Development, Paris.
22. OECD (1997) OECD Guidelines for the Testing of Chemicals: Genotoxicity, revised and new guidelines, adopted 1997. Organization for Economic Cooperation and Development, Paris.
23. Savage,J.R.K. (1976) Classification and relationships of induced chromosomal structural changes. J. Med. Genet., 13, 103-122.
24. Scott,D., Danford,N., Dean,B.J., Kirkland,D. and Richardson,C. (1983) In vitro chromosome aberration assays. In Report of the UKEMS Sub-committee on Guidelines for Mutagenicity Testing, Part I. Cambridge University Press, Cambridge, UK, pp. 41-64.
25. Scott,D., Galloway,S.M., Marshall,R.R. et al. (1991) Genotoxicity under extreme culture conditions. A report from ICPEMC Task Group 9. Mutat. Res., 257, 147-204.
26. Seo,K.S. and Lee,C.S. (1993) Mutagenicity of metal compounds using E. coli WP2 uvrA. Korean J. Microbiol., 31, 527-531.
27. Squier,C. and Rooney,L. (1976) The permeability of keratinised and non-keratinised oral epithelium to lanthanum in vivo. J. Ultrastruct. Res., 54, 280-295.
28. Yongxing,W., Xiarong,W. and Zichun,H. (2000) Genotoxicity of lanthanum(III) and gadolinium(III) in human peripheral blood lymphocytes. Bull. Environ. Contam. Toxicol., 64, 611-616.
29. Zeiger,E., Anderson,B., Haworth,S., Lawlor,T. and Mortelmans,K. (1992) Salmonella mutagenicity tests: V. Results from testing of 311 chemicals. Environ. Mol. Mutagen., 19, 2-141.
30. Zhang,A. and Zhang,Q. (1997) Study on the anti-mutagenic effects of lanthanum carbonate in chromosome aberration test, UDS test and micronucleus test. Wei Sheng Yen Chiu, 26, 306-309.